(Q46099211)

19 December 2017

title

An antiestrogen-responsive estrogen receptor-alpha mutant (D351Y) shows weak AF-2 activity in the presence of tamoxifen (English)

1 reference

19 December 2017

1 reference

Webb P

1

1 reference

19 December 2017

Nguyen P

2

1 reference

19 December 2017

Valentine C

3

1 reference

19 December 2017

Weatherman RV

4

1 reference

19 December 2017

Scanlan TS

5

1 reference

19 December 2017

Kushner PJ

6

1 reference

19 December 2017

language of work or name

English

0 references

publication date

1 December 2000

1 reference

19 December 2017

Journal of Biological Chemistry

published in

1 reference

19 December 2017

volume

275

1 reference

19 December 2017

issue

48

1 reference

19 December 2017

page(s)

37552-37558

1 reference

19 December 2017

Structure and function of the estrogen receptor.

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M007435200

The nuclear hormone receptor gene superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M007435200

Estrogen receptors: bioactivities and interactions with cell signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M007435200

Tamoxifen activation of the estrogen receptor/AP-1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M007435200

Nuclear receptor coactivators and corepressors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M007435200

Co-activators and co-repressors in the integration of transcriptional responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M007435200

Nuclear receptor coregulators: cellular and molecular biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M007435200

Dissection of the LXXLL nuclear receptor-coactivator interaction motif using combinatorial peptide libraries: discovery of peptide antagonists of estrogen receptors alpha and beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M007435200

The DRIP complex and SRC-1/p160 coactivators share similar nuclear receptor binding determinants but constitute functionally distinct complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M007435200

A tissue-specific coactivator of steroid receptors, identified in a functional genetic screen

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M007435200

The Angelman syndrome-associated protein, E6-AP, is a coactivator for the nuclear hormone receptor superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M007435200

Hormone-dependent coactivator binding to a hydrophobic cleft on nuclear receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M007435200

The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M007435200

Mechanisms of antihormone action

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M007435200

Estrogen receptor activation function 1 works by binding p160 coactivator proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M007435200

The steroid receptor coactivator-1 contains multiple receptor interacting and activation domains that cooperatively enhance the activation function 1 (AF1) and AF2 domains of steroid receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M007435200

Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M007435200

Tripartite steroid hormone receptor pharmacology: interaction with multiple effector sites as a basis for the cell- and promoter-specific action of these hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M007435200

Identification of constitutive and steroid-dependent transactivation domains in the mouse oestrogen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M007435200

Cellular mechanisms which distinguish between hormone- and antihormone-activated estrogen receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M007435200

Molecular basis of agonism and antagonism in the oestrogen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M007435200

Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M007435200

Aspartate 351 of estrogen receptor alpha is not crucial for the antagonist activity of antiestrogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M007435200

Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M007435200

Nuclear receptor-binding sites of coactivators glucocorticoid receptor interacting protein 1 (GRIP1) and steroid receptor coactivator 1 (SRC-1): multiple motifs with different binding specificities

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M007435200

Peptide antagonists of the human estrogen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M007435200

Titration by estrogen receptor activation function-2 of targets that are downstream from coactivators

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M007435200

Transcriptional activators differ in their responses to overexpression of TATA-box-binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M007435200

Estrogen receptor (ER) modulators each induce distinct conformational changes in ER alpha and ER beta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M007435200

Structure and specificity of nuclear receptor-coactivator interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M007435200

AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M007435200

Mutations in the conserved C-terminal sequence in thyroid hormone receptor dissociate hormone-dependent activation from interference with AP-1 activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M007435200

Coactivator-vitamin D receptor interactions mediate inhibition of the atrial natriuretic peptide promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M007435200

Selective Interaction of hsp90 with an Estrogen Receptor Ligand-binding Domain Containing a Point Mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M007435200

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M007435200

Estrogenic activity is increased for an antiestrogen by a natural mutation of the estrogen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M007435200

Functional domains of the human estrogen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M007435200

Different regions in activation function-1 of the human estrogen receptor required for antiestrogen- and estradiol-dependent transcription activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M007435200

21 January 2018

Identifiers

DOI

10.1074/JBC.M007435200

1 reference

19 December 2017

1 reference

19 December 2017